Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: The role of suppressor cells

No abstract is available for this paper.

• Publication year

  1977

• Venue

  International Journal of Cancer

• Publication date

  1977-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ijc.2910190503PMID 301122
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative measurements of T- and B-cell function in "variable" primary hypogammaglobulinaemia: evidence for a consistent B-cell defect.

  1977cited by this paper
• Factors interfering with immunological rejection of tumours.

  1976cited by this paper
• Critical evaluation of lymphocyte functions in urological cancer patients.

  1976cited by this paper
• Factors interfering with immunological rejection of tumours.

  1976cited by this paper
• Suppressor cells in the spleens of tumor-bearing mice: enrichment by centrifugation on hypaque-ficoll and characterization of the suppressor population.

  1976cited by this paper
• Letter: Improved localisation by subtraction of E.M.I. scans.

  1975cited by this paper
• Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.

  1975cited by this paper
• Functional activities of rosette separated human peripheral blood leukocytes.

  1975cited by this paper
• Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum.

  1975cited by this paper
• Hodgkin's disease. An immunodepleting and immunosuppressive disorder.

  1975cited by this paper
• AN IMMUNODEPLETING AND IMMUNOSUPPRESSIVE DISORDER

  1975cited by this paper
• Changes in the mitogen response of lymphoid cells with progressive tumor growth.

  1975cited by this paper
• Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells.

  1975cited by this paper
• Immunosuppressor T cells in tumor bearing host.

  1975cited by this paper
• Mixed leucocyte culture blocking factor activity in the plasma of patients with cancer.

  1974cited by this paper
• Immunity to Murine Sarcoma Virus-Induced Tumors

  1974cited by this paper
• Activation of suppressor T cells by tumour cells and specific antibody

  1974cited by this paper
• EVIDENCE OF SUPPRESSOR CELL ACTIVITY IN SPLEENS OF MICE BEARING PRIMARY TUMORS INDUCED BY MOLONEY SARCOMA VIRUS

  1974cited by this paper
• Inhibition of monocyte spreading. A direct in vitro test for assessing delayed-type hypersensitivity in man.

  1974cited by this paper
• Abnormalities of cell-mediated immunocompetence in genitourinary cancer.

  1974cited by this paper
• T cell suppression of contact sensitivity in the mouse. III. The role of macrophages and the specific triggering of nonspecific suppression

  1974cited by this paper
• T cell suppression of contact sensitivity in the mouse. II. The role of soluble suppressor factor and its interaction with macrophages

  1974cited by this paper
• Early detection of lymphocyte stimulation and mixed lymphocyte interaction in man with a semimicro protein synthesis assay.

  1974cited by this paper
• Enhancing T lymphocytes from tumor‐bearing mice suppress host resistance to a syngeneic tumor

  1974cited by this paper
• Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals.

  1974cited by this paper
• Non-specific immunostimulation in bronchogenic cancer.

  1974cited by this paper
• Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia.

  1974cited by this paper
• T-lymphocyte proliferation in mononucleosis.

  1973cited by this paper
• Immunologic status in lung cancer.

  1973cited by this paper
• Production by Stimulated Macrophages of Factors depressing Lymphocyte Transformation

  1973cited by this paper
• Isolation of normal T cells in chronic lymphatic leukaemia.

  1973cited by this paper
• Biological effects of the adjuvant Corynebacterium parvum. I. Inhibition of PHA, mixed lymphocyte and GVH reactivity.

  1972cited by this paper
• Clinical immunologic responsiveness in malignant disease. II. In vitro lymphocyte response to phytohemagglutinin and the effect of cytotoxic drugs.

  1972cited by this paper
• Biological effects of the adjuvant Corynebacterium parvum. II. Evidence for macrophage-T-cell interaction.

  1972cited by this paper
• Correlation Between Serum Alpha-Globulin and Plasma Inhibitory Effect on PHA-Stimulated Lymphocytes in Colon Cancer Patients 1

  1972cited by this paper
• SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTES

  1972cited by this paper
• Cytochemical identification of monocytes and granulocytes.

  1971cited by this paper
• Inhibition of phytohemagglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma.

  1971cited by this paper
• Reduced lymphocyte transformation in breast cancer.

  1971cited by this paper
• Impaired immunologic reactivity and recurrence following cancer surgery

  1970cited by this paper
• Clinical immunologic responsiveness in malignant disease. I. Delayed hypersensitivity reaction and the effect of cytotoxic drugs

  1970cited by this paper
• Lymphocyte response to P.H.A. in patients with non-lymphoid tumours.

  1970cited by this paper
• THE INTERACTION BETWEEN HUMAN MONOCYTES AND RED CELLS

  1970influential reference
• Deaf-mutism and type-II hyperlipoproteinaemia.

  1970cited by this paper
• A POPULATION OF LYMPHOCYTES BEARING A MEMBRANE RECEPTOR FOR ANTIGEN-ANTIBODY-COMPLEMENT COMPLEXES

  1970cited by this paper
• Delayed hypersensitivity in cancer patients: cutaneous and in vitro lymphocyte response to specific antigens.

  1969cited by this paper
• Separation of leukocytes from blood and bone marrow. Introduction.

  1968cited by this paper
• AN EXTENSION OF THE51Cr-RELEASE ASSAY FOR THE ESTIMATION OF MOUSE CYTOTOXINS

  1968cited by this paper

• Monocyte Fc-lgG Receptors Expression and Soluble Suppressor Factor in Skin Squamous Cell Carcinoma

  2022cites this paper
• Abnormal variation of the immune response as related to cancer

  2008cites this paper
• in long-term hemodyalysis patients immunological

  2008cites this paper
• Selective homing of phenotypically lytic cells within nasopharyngeal carcinoma biopsies: Numerous CD8‐ and CD16‐positive cells in the tumor

  2007cites this paper
• Patients with Cerebral Tumors

  2006cites this paper
• Correlationbetween Cytotoxicand SuppressorActivitiesof HumanPulmonary AlveolarMacrophages1

  2006cites this paper
• Enhanced expression of lipocortin-1 as a new immunosuppressive protein in cancer patients and its influence on reduced in vitro peripheral blood lymphocyte response to mitogens

  2005cites this paper
• Sera of lung cancer patients affect the release of Th1, Th2 and monocyte-derived cytokines, and the expression of IL-2Ralpha by normal, stimulated mononuclear cells.

  2004cites this paper
• Reversal of defective lymphoproliferation in postoperative patients with colon cancer

  2004cites this paper
• “Activated” monocytes in gastric cancer patients

  2004cites this paper
• Surface phenotypes of human peripheral blood mononuclear cells from patients with gastrointestinal carcinoma

  2004cites this paper
• Cytostatic activity on tumour cells of monocytes from patients with gastrointestinal cancer

  2004cites this paper
• Immunoregulation in hypersensitivity pneumonitis. I. Differences in T-cell and macrophage suppressor activity in symptomatic and asymptomatic pigeon breeders

  2004cites this paper
• Suppressor cells in the effector phase of autologous cytotoxic reactions in cancer patients

  2004cites this paper
• Mitogen responsiveness and inhibitory activity of mesenteric lymph node cells

  2004cites this paper
• Suppressor cell activity in patients with tonsillar carcinoma

  2004cites this paper
• Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma

  2004cites this paper
• The effect of indomethacin on the activation and effector function of suppressor cells from tumor-bearing mice

  2004cites this paper
• Depressed T lymphocyte function in brain tumor patients: Monocytes as suppressor cells

  2004cites this paper
• Correlations of breast carcinoma biomarkers and p53 tested by FASAY and immunohistochemistry.

  2003cites this paper
• Detection of intracellular interleukin‐2 production in peripheral T lymphocytes by flow cytometry in patients with pancreatobiliary malignancies

  2000cites this paper
• Macrophage suppression of T cell activation: a potential mechanism of peripheral tolerance.

  1999cites this paper
• The in vitro effect of Pidotimod on some immune functions in cancer patients.

  1997cites this paper
• Hyperthermia for Carcinoma of the Prostate

  1996cites this paper
• Immunologic dysfunction in cancer.

  1996cites this paper
• Membrane-bound/soluble IL-2 receptor (IL-2R) and levels of IL-1α, IL-2, and IL-6 in the serum and in the PBMC culture supernatants from 17 patients with hematological malignancies

  1995cites this paper
• The Immunology of Breast Cancer

  1995cites this paper
• The effects of thiopentone and propofol on delayed hypersensitivity reactions

  1995cites this paper
• Lack of correlation between defective cell-mediated-immunity and levels of secreted or circulating cytokines in a study of 90 cancer-patients.

  1994cites this paper
• Cell-Mediated Immune Response in Patients Undergoing Prostatic Hyperthermia

  1994cites this paper
• Cimetidine preserves non-specific immune function after colonic resection for cancer.

  1994cites this paper
• Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages.

  1993cites this paper
• Emergence of non-major-histocompatibility-complex-restricted lytic CD8+ cells in the blood of nasopharyngeal carcinoma patients

  1993cites this paper
• A comparative analysis of the characteristics and function of naturally occurring and drug-induced natural suppressor cells in mice.

  1993cites this paper
• Lymphoid cell distribution as prognostic factor in carcinoma of the uterine cervix

  1992cites this paper
• Suppressor T-cell levels are unreliable indicators of the impaired immune response following thermal injury.

  1992cites this paper
• T lymphocyte subsets and function in the peripheral blood of patients with urological cancer.

  1992cites this paper
• Contribution of monocytes to the decreased lymphoproliferative response to phytohemagglutinin in patients with lung cancer

  1991cites this paper
• Effects of local prostatic hyperthermia on human NK and T cell function.

  1991cites this paper
• The functional deficiency of B lymphocytes in patients with lung cancer is due to inadequate T-cell help and excessive suppression by T and non-T cells.

  1989cites this paper
• Increased relative frequency of suppressor monocytes in peripheral blood in early pregnancy

  1989cites this paper
• Abnormal Variation of the Immune System as Related to Cancer

  1989cites this paper
• Increased serum CD8 antigen level in childhood Hodgkin's disease relates to advanced stage and poor treatment outcome.

  1989cites this paper
• Decreased interleukin generation in patients with cancer of the digestive system. A correlation between interleukin 1 and interleukin 2 production

  1988cites this paper
• Role of macrophages in cytotoxic reaction against cells of lymphatic leukaemia L1210 in mice in the light of cytoenzymatic and ultracytoenzymatic studies.

  1988cites this paper
• Heutiger Stand der adjuvanten Therapie

  1988cites this paper
• [Suppressor function of the blood lymphocytes in patients with stomach cancer undergoing gastrectomy combined with splenectomy].

  1988cites this paper
• Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients.

  1988cites this paper
• Effects of cryopreservation on the mononuclear cells of patients with lung cancer and normal controls.

  1987cites this paper
• The effect of major surgery on T-lymphocyte function in patients with gastrointestinal cancer

  1987cites this paper
• Interleukin 2 (IL 2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL 2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients.

  1987cites this paper
• [Immunity and immunosuppression in tumor growth].

  1987cites this paper
• Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.

  1987cites this paper
• Potential impact of immunobiotechnology on cancer therapy

  1987cites this paper
• Regulation of human lymphocyte response in vitro by monocytes and their subsets.

  1986cites this paper
• Monocyte regulation of lymphokine production in cancer patients.

  1986cites this paper
• In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis.

  1986cites this paper
• Immune defects in chronic renal impairment: evidence for defective regulation of lymphocyte response by macrophages from patients with chronic renal impairment on haemodialysis.

  1986cites this paper
• The incidence of malignant neoplasma in lon g-term hemodyalysis patients

  1986cites this paper
• PHA responsiveness and adherent cell-lymphocyte interactions in patients with advanced malignant tumors of the ovary prior to treatment and during chemotherapy.

  1986cites this paper
• Tumor growth versus fetal development--similarities and confusions.

  1986cites this paper
• Augmented natural killer activity in ovarian cancer patients treated with cimetidine.

  1986cites this paper
• Decreased interleukin−2 production in patients with gastrointestinal cancer

  1986cites this paper
• Peripheral Blood Lymphocyte Response to Exogenous Interleukin 2 by PHA-Prestimulated and Non-PHA-Prestimulated Cells in Patients with Cancer

  1986cites this paper
• Role of the spleen on immunosuppression in esophageal and gastric cancer

  1986cites this paper
• Immunoregulatory leucocyte subset typing and PHA response in relation to the nutritional state in cancer patients with gastrointestinal neoplasia.

  1986cites this paper
• Assessment of cell‐mediated immunity in a British population using multiple skin test antigens

  1986cites this paper
• Immunogenetic studies in retinoblastoma.

  1986cites this paper
• Suppressive Effect of Monocytes in Vitro in Patients with Carcinoma of the Uterine Cervix

  1986cites this paper
• Changes in Splenic Macrophage Mac Antigen Expression During Tumor Growth: A Kinetic Study of Accessory Cell Function and Antigen‐Defined Phenotypes

  1986cites this paper
• Monocyte and lymphocyte interaction in patients with advanced cancer. Evidence for deficient IL‐1 production

  1985cites this paper
• Segregation of peripheral blood lymphocytes in sarcoidosis according to their affinity to insolubilized histamine.

  1985cites this paper
• CorrelationbetweenCytotoxicandSuppressor Activitiesof HumanPulmonary AlveolarMacrophages1

  1985cites this paper
• The Macrophage and Cancer

  1985cites this paper
• In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

  1985cites this paper
• Antitumour Lymphocyte Responses

  1985cites this paper
• The role of shed Fc receptor in the regulation of lymphocyte response to phytohaemagglutinin (PHA).

  1985cites this paper
• Suppression of B-lymphocyte function by T-lymphocytes in patients with advanced lung cancer.

  1985cites this paper
• Correlation between cytotoxic and suppressor activities of human pulmonary alveolar macrophages.

  1985cites this paper
• Immunosuppressor control as a modality of cancer treatment: effect of plasma adsorption with Staphylococcus aureus protein A.

  1985cites this paper
• Suppression of delayed-type hypersensitivity mediated by macrophage-like cells in mice with experimental liver injury.

  1985cites this paper
• Tumour-induced suppressor macrophages in rats: differences in their suppressive effects on the Con A and PHA responses.

  1984cites this paper
• Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).

  1984cites this paper
• Monoclonal antibody‐defined T‐cell phenotypes and phytohemagglutinin reactivity of E‐rosette‐forming circulating lymphocytes from untreated chronic myelocytic leukemia patients

  1984cites this paper
• Effects of Tumours on the Immune System

  1984cites this paper
• Immunomodulating activities associated with the cytosol fraction of a 3-methylcholanthrene-induced rat fibrosarcoma.

  1984cites this paper
• Spontaneous suppressor cell activity in the peripheral blood of patients with malignant and chronic inflammatory bowel diseases.

  1984cites this paper
• Isolation and functional characteristics of FcR+ and FcR- human monocyte subsets.

  1984cites this paper
• Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2

  1984cites this paper
• Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells

  1984cites this paper
• Mitogen-induced gamma interferon production in peripheral blood lymphocytes from patients with colorectal tumors.

  1984cites this paper
• Monocyte Fc-IgG receptors expression and soluble suppressor factor in skin squamous cell carcinoma.

  1983cites this paper
• Suppressor cells and survival of patients with advanced gastric cancer.

  1983cites this paper
• [Cell-mediated immunity of experimental brain tumors].

  1983cites this paper
• T cell subsets and soluble immune response suppressor (SIRS) factor in skin squamous cell carcinoma.

  1983cites this paper
• Enhancement of T lumphocyte proliferative response to mitogens by indomethacin in breast and colorectal cancer patients

  1983cites this paper
• Re-evaluation of immunological parameters in immunotherapy for advanced carcinoma of the digestive tract

  1983cites this paper
• BCG-induced macrophages as suppressor cells.

  1983cites this paper
• T lymphocyte subsets in the peripheral blood of patients with benign and malignant breast disease.

  1983cites this paper
• Concanavalin A‐induced and spontaneous suppressor cell activities in peripheral blood lymphocytes and spleen cells from gastric cancer patients

  1983cites this paper